News

Patritumab deruxtecan shows promising survival rates and manageable safety in treating leptomeningeal metastatic disease, ...
Management of chronic thromboembolic pulmonary hypertension (CTEPH) includes multimodal therapy that depends on expert ...
Supreme Court allows Trump to remove 3 Democrats on the Consumer Product Safety Commission.
Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...
Metabotropic glutamate receptor 2 (mGluR2) is a therapeutic target for several neuropsychiatric disorders. An mGluR2 function in etiology could be unveiled by positron emission tomography (PET). In ...